» Articles » PMID: 19734440

Does One Size Fit All? Investigating Heterogeneity in Men's Preferences for Benign Prostatic Hyperplasia Treatment Using Mixed Logit Analysis

Overview
Publisher Sage Publications
Date 2009 Sep 8
PMID 19734440
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, the authors demonstrate how mixed logit analysis of discrete choice experiment (DCE) data can provide information about unobserved preference heterogeneity. Their application investigates unobserved heterogeneity in men's preferences for benign prostatic hyperplasia (BPH) treatment. They use a DCE to elicit preferences for seven characteristics of BPH treatment: time to symptom improvement, sexual and nonsexual treatment side effects, risks of acute urinary retention and surgery, cost of treatment, and reduction in prostate size. They investigate the importance of these characteristics and the trade-offs men are willing to make between them. Preferences are elicited from a sample of 100 men attending an outpatient clinic in Ireland. The authors find all treatment characteristics are significant determinants of treatment choice. There is significant preference heterogeneity in the population for four treatment characteristics: time to symptom improvement, treatment reducing prostate size, risk of surgery, and sexual side effects. The importance of preference heterogeneity at the policy level within the context of shared decision making is discussed.

Citing Articles

Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.

Fitriana T, Roudijk B, Purba F, Busschbach J, Stolk E Pharmacoeconomics. 2022; 40(Suppl 2):157-167.

PMID: 36348155 PMC: 9758088. DOI: 10.1007/s40273-022-01210-1.


The Public's Preferences for Psychological Interventions During the COVID-19 Pandemic: A Discrete Choice Experiment.

Li H, Liu S, Xue H, Yuan H, Zhang X Front Psychiatry. 2022; 13:805512.

PMID: 35573350 PMC: 9091726. DOI: 10.3389/fpsyt.2022.805512.


A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.

Liu F, Hu H, Wang J, Chen Y, Hui S, Hu M Front Public Health. 2021; 9:653450.

PMID: 33842426 PMC: 8032943. DOI: 10.3389/fpubh.2021.653450.


The Best of Both Worlds: An Example Mixed Methods Approach to Understand Men's Preferences for the Treatment of Lower Urinary Tract Symptoms.

Ikenwilo D, Heidenreich S, Ryan M, Mankowski C, Nazir J, Watson V Patient. 2017; 11(1):55-67.

PMID: 28660567 DOI: 10.1007/s40271-017-0263-7.


Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?.

Vass C, Payne K Pharmacoeconomics. 2017; 35(9):859-866.

PMID: 28536955 PMC: 5563347. DOI: 10.1007/s40273-017-0518-0.